Background illustration for clinical trials search

Paid Clinical Trials Stamford

Discover 1,022 paid clinical trials in Stamford, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

for
Prostate Cancer (Adenocarcinoma)
Location: The Bronx NY, West Haven CT, Scranton PA,
Sponsor: Canadian Cancer Trials Group

Sex: Male

Age: 18+

Code: NCT06592924

Phase3, Recruiting

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: New York NY, New Haven CT, Philadelphia PA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT03972657

Phase1, Phase2, Recruiting

A Study to Assess Growth in Children With Idiopathic Short Stature

for
Idiopathic Short Stature
Location: The Bronx NY, Garden City NY, Hartford CT, Princeton NJ,
Sponsor: BioMarin Pharmaceutical

Sex: All

Age: 2 - 16

Code: NCT06309979

Recruiting

I-DECIDE After Bronchiolitis Hospitalization

for
Bronchiolitis Acute
Location: The Bronx NY, Hackensack NJ, New York NY, New Haven CT,
Sponsor: Seattle Children's Hospital

Sex: All

Age: 0 - 2

Code: NCT07243652

Recruiting

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

for
Rheumatic Joint Disease
Location: New York NY, Lake Success NY, Hackensack NJ,
Sponsor: Duke University

Sex: All

Age: 0 - 21

Code: NCT02418442

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

for
In-Stent Restenosis, Cardiovascular Diseases,
Location: Bronx NY, New York NY, New York City NY, New Haven CT,
Sponsor: Concept Medical Inc.

Sex: All

Age: 18 - 70+

Code: NCT05908331

Recruiting

StrokeNet Thrombectomy Endovascular Platform

for
Ischemic Stroke
Location: The Bronx NY, Stony Brook NY, New York NY, New Haven CT,
Sponsor: Medical University of South Carolina

Sex: All

Age: 18+

Code: NCT06289985

Recruiting

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

for
Advanced Solid Tumor, TNBC - Triple-Negative Breast Cancer,
Location: New York NY, The Bronx NY, New Haven CT, Ann Arbor MI,
Sponsor: SillaJen, Inc.

Sex: All

Age: 18+

Code: NCT05768932

Phase1, Recruiting

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

for
Prostate Cancer,
Location: The Bronx NY, Lake Success NY, Mineola NY, New York NY,
Sponsor: Janux Therapeutics

Sex: Male

Age: 18 - 70+

Code: NCT05519449

Phase1, Recruiting

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

for
Prostate Cancer
Location: The Bronx NY, Hartford CT, Washington D.C. DC, Montreal,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT05803941

Recruiting

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

for
Breast Neoplasms, Breast Cancer, Breast Tumors, Angiosarcoma,
Location: The Bronx NY, New York NY, New Haven CT,
Sponsor: QuantumLeap Healthcare Collaborative

Sex: All

Age: 18+

Code: NCT01042379

Phase2, Recruiting

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

for
Myelodysplastic Syndromes, Acute Myeloid Leukemia,
Location: The Bronx NY, Mineola NY, New York NY, Hackensack NJ,
Sponsor: Taiho Oncology, Inc.

Sex: All

Age: 18+

Code: NCT04256317

Phase2, Phase3, Recruiting

Buprenorphine and Integrated HIV Care Evaluation

for
Opioid-Related Disorders, HIV Infections, AIDS
Location: New York NY, New Haven CT, Providence RI, Baltimore MD,
Sponsor: The New York Academy of Medicine

Sex: All

Age: 18+

Code: NCT00124358

Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

for
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer,
Location: The Bronx NY, Hackensack NJ, New York NY, New Haven CT,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06881784

Phase3, Recruiting

Digoxin Medulloblastoma Study

for
Medulloblastoma, Medulloblastoma, Non-WNT/Non-SHH
Location: The Bronx NY, Hartford CT, Baltimore MD,
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 1 - 30

Code: NCT06701812

Phase2, Recruiting

Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2

for
Neurotrophic Keratopathy
Location: The Bronx NY, Danbury CT, Palisades Park NJ, Norfolk VA,
Sponsor: ReGenTree, LLC

Sex: All

Age: 18+

Code: NCT05555589

Phase3, Recruiting

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

for
Carcinoma, Non-Small-Cell Lung
Location: The Bronx NY, Mineola NY, New York NY, New Haven CT,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06667076

Phase2, Recruiting

A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

for
Small-cell Lung Cancer
Location: The Bronx NY, Stony Brook NY, New Haven CT, Broomall PA,
Sponsor: Zai Lab (Shanghai) Co., Ltd.

Sex: All

Age: 18+

Code: NCT07218146

Phase3, Recruiting

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

for
Squamous Cell Carcinoma of Head and Neck
Location: The Bronx NY, Mineola NY, New York NY, New Haven CT,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07276399

Phase3, Recruiting

Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders

for
Immune Thrombocytopenia
Location: The Bronx NY, New Haven CT, Boston MA, Fairfax VA,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07104565

Phase2, Recruiting